Samson Melanie, Labrie Fernand, Luu-The Van
Horm Mol Biol Clin Investig. 2010 Jan 1;1(2):67-72. doi: 10.1515/HMBCI.2010.009.
Although it is well recognized that 5α-reductases possess higher affinity for 4-androstenedione than testosterone, and the affinity of 4-androstenedione is higher for 5α-reductases than 17β-hydroxysteroid dehydrogenases, it is generally believed that dihydrotestosterone is necessarily produced by the transformation of testosterone into dihydrotestosterone, suggesting that the step catalyzed by 17β-hydroxysteroid dehydrogenase precedes the step catalyzed by 5α-reductase. This interpretation is in contradiction with the enzymatic kinetic law that suggests that the 5α-reduction step that catalyzes the transformation of 4-dione into 5α-androstane-3,17-dione precedes the 17keto-reduction step.
To verify which of these two pathways is operative, we quantified mRNA expression levels of steroidogenic enzymes in prostate carcinoma DU-145 cells by real-time PCR and determined the metabolites produced after incubation with [14C]4-dione in the presence and absence of a 5α-reductase inhibitor and analyzed the metabolites produced by thin layer chromatography and HPLC.
Real-time PCR analysis strongly suggests that the new type 3 5α-reductase is responsible for 5α-reductase activity in DU-145 cells. Steroid profile analysis shows that in the absence of inhibitor 5α-androstanedione is first produced, followed by the production of androsterone and dihydrotestosterone. The concentration of testosterone was not detectable. In the presence of Finasteride, an inhibitor of 5α-reductase, there was no transformation of 4-androstenedione and also there was no production of testosterone. The present data clearly indicate that the biosynthesis of dihydrotestosterone in DU-145 cells does not require testosterone as intermediate, and the step catalyzed by 5α-reductase precedes the step catalyzed by 17β-hydroxysteroid dehydrogenase.
尽管人们普遍认识到5α-还原酶对4-雄烯二酮的亲和力高于睾酮,且4-雄烯二酮对5α-还原酶的亲和力高于17β-羟基类固醇脱氢酶,但通常认为双氢睾酮必然是由睾酮转化为双氢睾酮产生的,这表明由17β-羟基类固醇脱氢酶催化的步骤先于由5α-还原酶催化的步骤。这种解释与酶动力学定律相矛盾,酶动力学定律表明催化4-二酮转化为5α-雄甾烷-3,17-二酮的5α-还原步骤先于17-酮还原步骤。
为了验证这两条途径中哪一条起作用,我们通过实时PCR定量前列腺癌DU-145细胞中类固醇生成酶的mRNA表达水平,并在存在和不存在5α-还原酶抑制剂的情况下,测定与[14C]4-二酮孵育后产生的代谢产物,并通过薄层色谱和高效液相色谱分析产生的代谢产物。
实时PCR分析强烈表明新型3型5α-还原酶负责DU-145细胞中的5α-还原酶活性。类固醇谱分析表明,在没有抑制剂的情况下,首先产生5α-雄甾烷二酮,随后产生雄酮和双氢睾酮。未检测到睾酮浓度。在5α-还原酶抑制剂非那雄胺存在的情况下,4-雄烯二酮没有转化,也没有睾酮产生。目前的数据清楚地表明,DU-145细胞中双氢睾酮的生物合成不需要睾酮作为中间体,且由5α-还原酶催化的步骤先于由17β-羟基类固醇脱氢酶催化的步骤。